National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.    


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • P Series Deadlines: Jan. 25, May 25, Sep. 25
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7

PAR-20-077 Expiration Date May 8, 2023




Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

January 25, 2023